CELZ
NASDAQ · Biotechnology
Creative Medical Technology
$1.24
+0.04 (+3.33%)
Open$1.23
Previous Close$1.20
Day High$1.25
Day Low$1.18
52W High$6.25
52W Low$0.62
Volume—
Avg Volume31.76M
Market Cap6.73M
P/E Ratio—
EPS$-2.04
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,592.7% upside
Current
$1.24
$1.24
Target
$33.39
$33.39
$22.85
$33.39 avg
$43.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 12.4K | 30.5K | 749.0K |
| Net Income | -12,456,808 | -27,647,662 | -154,552 |
| Profit Margin | -99,916.8% | -94,921.0% | -20.6% |
| EBITDA | -12,507,309 | -29,301,956 | -155,667 |
| Free Cash Flow | — | — | -141,548 |
| Rev Growth | -59.5% | -59.5% | +1.8% |
| Debt/Equity | — | — | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.68 | -0.45% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $412.84 | -1.20% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.12 | -0.01% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $508.33 | -1.57% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.64 | -0.29% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $227.29 | +0.07% | 35.2 | 28.41B |